Endocrine Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil; Universidade Federal do Rio Grande do Sul, Faculty of Medicine, Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Porto Alegre, Rio Grande do Sul, Brazil.
Nephrology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Microvasc Res. 2022 Sep;143:104378. doi: 10.1016/j.mvr.2022.104378. Epub 2022 May 17.
The Erb-b2 receptor tyrosine kinase 3 (ERBB3) is involved in autoimmune processes related to type 1 diabetes mellitus (T1DM) pathogenesis. Accordingly, some studies have suggested that single nucleotide polymorphisms (SNPs) in the ERBB3 gene confer risk for T1DM. Proliferation-associated protein 2G4 (PA2G4) is another candidate gene for this disease because it regulates cell proliferation and adaptive immunity. Moreover, PA2G4 regulates ERBB3. To date, no study has evaluated the association of PA2G4 SNPs and T1DM.
To evaluate the association of ERBB3 rs705708 (G/A) and PA2G4 rs773120 (C/T) SNPs with T1DM and its clinical and laboratory characteristics.
This case-control study included 976 white subjects from Southern Brazil, categorized into 501 cases with T1DM and 475 non-diabetic controls. The ERBB3 and PA2G4 SNPs were genotyped by allelic discrimination-real-time PCR.
ERBB3 rs705708 and PA2G4 rs773120 SNPs were not associated with T1DM considering different inheritance models and also when controlling for covariables. However, T1DM patients carrying the ERBB3 rs705708 A allele developed T1DM at an earlier age vs. G/G patients. Interestingly, in the T1DM group, the rs705708 A allele was associated with lower prevalence of diabetic retinopathy and arterial hypertension as well as with improved renal function (higher estimated glomerular filtration rate and lower urinary albumin excretion levels) compared to G/G patients.
Although no association was observed between the ERBB3 rs705708 and PA2G4 rs773120 SNPs and T1DM, the rs705708 A allele was associated, for the first time in literature, with lower prevalence of diabetic retinopathy and arterial hypertension. Additionally, this SNP was associated with improved renal function.
表皮生长因子受体-2 相关受体酪氨酸激酶 3(ERBB3)参与与 1 型糖尿病(T1DM)发病机制相关的自身免疫过程。相应地,一些研究表明 ERBB3 基因中的单核苷酸多态性(SNP)赋予 T1DM 的风险。增殖相关蛋白 2G4(PA2G4)是该疾病的另一个候选基因,因为它调节细胞增殖和适应性免疫。此外,PA2G4 调节 ERBB3。迄今为止,尚无研究评估 PA2G4 SNP 与 T1DM 的关联。
评估 ERBB3 rs705708(G/A)和 PA2G4 rs773120(C/T)SNP 与 T1DM 及其临床和实验室特征的关联。
本病例对照研究纳入了来自巴西南部的 976 名白人受试者,分为 501 例 T1DM 患者和 475 例非糖尿病对照。通过等位基因鉴别实时 PCR 对 ERBB3 和 PA2G4 SNP 进行基因分型。
考虑到不同的遗传模式,以及在控制协变量时,ERBB3 rs705708 和 PA2G4 rs773120 SNP 与 T1DM 均无关联。然而,携带 ERBB3 rs705708 A 等位基因的 T1DM 患者比 G/G 患者更早发病。有趣的是,在 T1DM 组中,与 G/G 患者相比,rs705708 A 等位基因与糖尿病视网膜病变和动脉高血压的发生率较低以及肾功能改善(更高的估计肾小球滤过率和更低的尿白蛋白排泄水平)相关。
尽管未观察到 ERBB3 rs705708 和 PA2G4 rs773120 SNP 与 T1DM 之间存在关联,但 rs705708 A 等位基因与文献首次报道的糖尿病视网膜病变和动脉高血压的发生率较低相关。此外,该 SNP 与肾功能改善相关。